Henry, T.
Sun, R.
Lerousseau, M.
Estienne, T.
Robert, C.
Besse, B.
Robert, C.
Paragios, N.
Deutsch, E.
Funding for this research was provided by:
Fondation pour la Recherche Médicale (DIC20161236437)
Fondation ARC pour la Recherche sur le Cancer (SIGN'IT20181007805)
Article History
Received: 20 June 2022
Accepted: 21 September 2022
First Online: 14 October 2022
Competing interests
: R.S. reports research and travel grants from Fondation ARC and Université Paris-Saclay and support from Inserm and Fondation Bettencourt Schueller outside of the submitted work. Ca.R. is a consultant advisor for Amgen, AstraZeneca, BMS, Merck, MSD, Novartis, Pierre Fabre, Roche and Sanofi. E.D. reports grants and personal fees from Roche Genentech, grants from Servier, grants from Astrazeneca, grants and personal fees from Merck Serono, grants from BMS, and grants from MSD, outside the submitted work. All remaining authors have declared no conflicts of interest.